Stock Events

Arcturus Therapeutics (ARCT) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.98
-1.39
-0.8
-0.21

Details

Expected EPS
-1.233607
Actual EPS
-1
Surprise EPS
0.23
Surprise Percent
+18.94%

Description

Arcturus Therapeutics (ARCT) has reported earnings of -1 per share for Q2 2024.

0 Comments

Share your thoughts